Upstream Bio Inc. (UPB) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Upstream Bio Inc.

NASDAQ: UPB · Real-Time Price · USD
18.63
0.04 (0.22%)
At close: Oct 03, 2025, 3:59 PM
18.50
-0.70%
After-hours: Oct 03, 2025, 07:07 PM EDT

Upstream Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Net Income
-62.81M -20.54M -23.87M
Depreciation & Amortization
89K 60K 7K
Stock-Based Compensation
6M 3.43M 1.28M
Other Working Capital
371K -5.9M 3.36M
Other Non-Cash Items
-4.33M -16.57M 149K
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
1.87M -4.3M 3.41M
Operating Cash Flow
-59.17M -37.93M -19.02M
Capital Expenditures
-511K -144K -82K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-290.61M -128.99M n/a
Sales Maturities Of Investments
231.63M 46.29M n/a
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
-59.48M -82.84M -82K
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
-3.74M 118K -37K
Financial Cash Flow
418.91M 129.55M 9.96M
Net Cash Flow
300.25M 8.78M -9.14M
Free Cash Flow
-59.68M -38.07M -19.1M